What Happened?
Cambridge, MA-based Checkmate-Pharmaceuticals Appointed Barry Labinger as President and Chief Executive Officer
About the Company
Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat cancer. Checkmate`s product candidate, CMP-001, is an advanced generation TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body`s innate immune system to attack tumors in combination with other therapies.
About the Person
Barry Labinger is President and Chief Executive Officer at Checkmate Pharmaceuticals. Previously, Barry held various senior HR leadership roles in the industry.
Info Source
News
Short Profile